MMedXYNews
Ask AIHomeVideos
MedXY AI/MedXY News/Section: Neurology
Neurology

Unraveling the Link Between Anxiety and Dizziness in Vestibular Schwannoma Patients: Insights From a Retrospective Cohort Study

MedXY Editorial TeamOct 4, 2025
anxietyDizzinessVestibular Schwannoma

Highlight

1. Anxiety correlates significantly with higher dizziness severity in patients diagnosed with vestibular schwannoma (VS).
2. Each point increase in anxiety severity (GAD-7 score) corresponds to a clinically meaningful rise in dizziness handicap (DHI score).
3. Psychological factors might influence symptom perception and burden in VS beyond direct tumor effects.
4. Integrating mental health assessment could improve holistic care for VS patients experiencing dizziness.

Study Background and Disease Burden

Vestibular schwannoma (VS), also known as acoustic neuroma, is a benign, typically slow-growing tumor arising from Schwann cells of the vestibulocochlear nerve. Patients commonly present with hearing loss, tinnitus, and dizziness—complaints that significantly impair quality of life. While hearing loss and tinnitus have been extensively studied, the determinants and characteristics of dizziness in VS remain less well understood. Dizziness can include vertigo, imbalance, or subjective unsteadiness, all contributing to disability and fall risk. Psychological factors such as anxiety are prevalent in chronic neurological conditions and may modulate symptom perception and severity. Identifying factors associated with dizziness could inform better symptom management and personalized care strategies.

Study Design

This retrospective cohort study analyzed data from 109 adults with radiologically confirmed VS at Washington University (St Louis, Missouri) from June 2004 to January 2025. All included patients completed vestibular function testing and scored their dizziness handicap using the Dizziness Handicap Inventory (DHI), a validated self-reported questionnaire assessing the physical, emotional, and functional impact of dizziness. Anxiety was quantified using the Generalized Anxiety Disorder-7 (GAD-7) scale and by documented history of anxiety disorders. The primary outcome was the severity of dizziness, operationalized as the continuous DHI score. Multivariate analyses adjusted for potential confounders to determine independent associations between anxiety measures and dizziness severity.

Key Findings

The cohort’s mean age was 61 years (SD 14), with 52% female. The mean DHI score was 27 (SD 24), indicating mild to moderate dizziness handicap on average but with wide variability. Patients reporting a history of anxiety had significantly higher mean DHI scores by 13.7 points (95% CI, 4.2 to 23.2), reflecting greater dizziness severity. Notably, for each incremental point increase in anxiety severity measured by GAD-7, the DHI score rose by 2.6 points (95% CI, 2.0 to 3.3), suggesting a dose-dependent relationship. After adjusting for covariates such as age, sex, tumor size, and hearing loss, the association persisted with a 1.9-point increase in DHI per GAD-7 point (95% CI, 1.3 to 2.6). On average, anxiety history was independently linked with a 10.6-point greater dizziness handicap (95% CI, 2.4 to 18.7). These findings underscore a robust association between anxiety and subjective dizziness burden in VS patients.

Expert Commentary

This study adds compelling evidence to the evolving understanding that dizziness in VS extends beyond purely vestibular pathology to include significant psychological components. The use of validated scales for both dizziness and anxiety, along with adjustment for clinical confounders, strengthens the reliability of these findings. The biological plausibility is supported by known interactions between vestibular dysfunction and anxiety circuits in the brain, which may amplify symptom perception. Clinically, these results advocate for routine anxiety screening in VS patients presenting with dizziness. Multifaceted approaches incorporating vestibular rehabilitation alongside anxiety management could enhance patient outcomes. Nonetheless, the retrospective design limits causal inference, and prospective longitudinal studies are warranted to elucidate directional relationships and evaluate intervention efficacy. Additionally, underlying mechanisms remain to be clarified through neuroimaging and neurophysiological research.

Conclusion

This retrospective cohort study highlights a significant psychological dimension to dizziness in adults with vestibular schwannoma, demonstrating that anxiety correlates with increased dizziness severity independently of tumor characteristics. Recognizing and addressing anxiety in this population could improve symptom control and quality of life. Future research should focus on prospective validation, mechanistic exploration, and development of integrated therapeutic strategies combining vestibular and mental health care in VS management.

References

Wilson T, Kallogjeri D, Sinks B, English L, Jiramongkolchai P, Shew M, Herzog J, Buchman C, Piccirillo J, Durakovic N. Factors Associated With Dizziness Among Patients With Vestibular Schwannoma. JAMA Otolaryngol Head Neck Surg. 2025 Oct 2:e252849. doi: 10.1001/jamaoto.2025.2849. Epub ahead of print. PMID: 41037309; PMCID: PMC12492295.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Long-Term Clinical Outcomes of Zika-Related Microcephaly: Insights from the First Five Years of Life

NeurologyNov 5, 2026

Evaluating Blood-Based Biomarkers GFAP and UCH-L1 for Diagnosing Intracranial Injury in Mild Traumatic Brain Injury Patients in the Emergency Department

NeurologyNov 5, 2026

Environmental Exposure to Water Pollutants and Progressive Supranuclear Palsy Risk: Insights from the UK Biobank

NeurologyNov 5, 2026
Loading comments...

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story